Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000899140-21-000496
Filing Date
2021-05-18
Accepted
2021-05-18 16:32:04
Documents
2
Group Members
POINT72 CAPITAL ADVISORS, INC.STEVEN A. COHEN

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G f051821a.htm SC 13G 41537
2 JOINT FILING AGREEMENT f051821b.htm EX-99.1 2310
  Complete submission text file 0000899140-21-000496.txt   45553
Mailing Address 35 PARKWOOD DRIVE BABRAHAM RESEARCH CAMPUS CAMBRIDGE X0 CB22 3AT
Business Address 35 PARKWOOD DRIVE BABRAHAM RESEARCH CAMPUS CAMBRIDGE X0 CB22 3AT 44 1223 497400
F-star Therapeutics, Inc. (Subject) CIK: 0001566373 (see all company filings)

EIN.: 522386345 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-89626 | Film No.: 21936461
SIC: 2834 Pharmaceutical Preparations

Mailing Address 72 CUMMINGS POINT ROAD STAMFORD CT 06902
Business Address 72 CUMMINGS POINT ROAD STAMFORD CT 06902 203-890-2000
Point72 Asset Management, L.P. (Filed by) CIK: 0001603466 (see all company filings)

EIN.: 465064661 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G